FDA's Janet Woodcock Addresses Sunscreen TEA 'Turmoil'
This article was originally published in The Rose Sheet
Executive Summary
At a CHPA conference in Washington, the CDER director offered perspective on the center’s work on OTC drug monograph modernization and sunscreen ingredient TEAs. Marketing experience in foreign countries means only that a sunscreen ingredient may be eligible for GRASE consideration, she emphasized.